Medicalg (MDG) - Net Assets
Based on the latest financial reports, Medicalg (MDG) has net assets worth zł62.94 Million PLN (≈ $17.32 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł111.36 Million ≈ $30.65 Million USD) and total liabilities (zł48.42 Million ≈ $13.33 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MDG intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł62.94 Million |
| % of Total Assets | 56.52% |
| Annual Growth Rate | 26.63% |
| 5-Year Change | -62.78% |
| 10-Year Change | -22.18% |
| Growth Volatility | 153.82 |
Medicalg - Net Assets Trend (2010–2024)
This chart illustrates how Medicalg's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Medicalg to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Medicalg (2010–2024)
The table below shows the annual net assets of Medicalg from 2010 to 2024. For live valuation and market cap data, see Medicalg stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | zł77.19 Million ≈ $21.24 Million |
-16.62% |
| 2023-12-31 | zł92.57 Million ≈ $25.48 Million |
+15.59% |
| 2022-12-31 | zł80.08 Million ≈ $22.04 Million |
+68.96% |
| 2021-12-31 | zł47.39 Million ≈ $13.04 Million |
-77.14% |
| 2020-12-31 | zł207.37 Million ≈ $57.07 Million |
-7.72% |
| 2019-12-31 | zł224.72 Million ≈ $61.85 Million |
-2.62% |
| 2018-12-31 | zł230.76 Million ≈ $63.51 Million |
+13.27% |
| 2017-12-31 | zł203.73 Million ≈ $56.07 Million |
-5.22% |
| 2016-12-31 | zł214.95 Million ≈ $59.16 Million |
+116.71% |
| 2015-12-31 | zł99.19 Million ≈ $27.30 Million |
+9.25% |
| 2014-12-31 | zł90.79 Million ≈ $24.99 Million |
+12.19% |
| 2013-12-31 | zł80.93 Million ≈ $22.27 Million |
+9.63% |
| 2012-12-31 | zł73.82 Million ≈ $20.32 Million |
+521.22% |
| 2011-12-31 | zł11.88 Million ≈ $3.27 Million |
+319.97% |
| 2010-12-31 | zł2.83 Million ≈ $778.68K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Medicalg's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 13259963382.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | zł995.00K | 1.29% |
| Other Comprehensive Income | zł-1.34 Million | -1.74% |
| Other Components | zł210.98 Million | 273.38% |
| Total Equity | zł77.17 Million | 100.00% |
Medicalg Competitors by Market Cap
The table below lists competitors of Medicalg ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Neptune Digital Assets Corp
V:NDA
|
$74.24 Million |
|
MGI Digital
PA:ALMDG
|
$74.24 Million |
|
Taiwan Alpha Electronic Co Ltd
TWO:6204
|
$74.24 Million |
|
Al-Salam Real Estate Investment Trust
KLSE:5269
|
$74.27 Million |
|
GeeCee Ventures Limited
NSE:GEECEE
|
$74.22 Million |
|
Team Inc
NYSE:TISI
|
$74.19 Million |
|
Kyobo With Special Purpose Acq
KQ:205100
|
$74.19 Million |
|
MSC Co. Ltd
KQ:009780
|
$74.19 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medicalg's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 92,557,000 to 77,174,000, a change of -15,383,000 (-16.6%).
- Net loss of 16,081,000 reduced equity.
- Other comprehensive income increased equity by 698,001.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł-16.08 Million | -20.84% |
| Other Comprehensive Income | zł698.00K | +0.9% |
| Other Changes | zł-1.00 | -0.0% |
| Total Change | zł- | -16.62% |
Book Value vs Market Value Analysis
This analysis compares Medicalg's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.50x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 23.87x to 3.50x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | zł1.14 | zł27.10 | x |
| 2011-12-31 | zł4.77 | zł27.10 | x |
| 2012-12-31 | zł25.67 | zł27.10 | x |
| 2013-12-31 | zł23.65 | zł27.10 | x |
| 2014-12-31 | zł26.27 | zł27.10 | x |
| 2015-12-31 | zł28.70 | zł27.10 | x |
| 2016-12-31 | zł49.06 | zł27.10 | x |
| 2017-12-31 | zł46.83 | zł27.10 | x |
| 2018-12-31 | zł52.64 | zł27.10 | x |
| 2019-12-31 | zł54.29 | zł27.10 | x |
| 2020-12-31 | zł50.11 | zł27.10 | x |
| 2021-12-31 | zł10.42 | zł27.10 | x |
| 2022-12-31 | zł16.61 | zł27.10 | x |
| 2023-12-31 | zł17.50 | zł27.10 | x |
| 2024-12-31 | zł7.75 | zł27.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medicalg utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -20.84%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -67.00%
- • Asset Turnover: 0.23x
- • Equity Multiplier: 1.37x
- Recent ROE (-20.84%) is below the historical average (-15.32%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | 67.51% | 46.50% | 1.12x | 1.30x | zł1.63 Million |
| 2011 | 25.30% | 51.78% | 0.43x | 1.13x | zł1.82 Million |
| 2012 | 10.08% | 67.86% | 0.15x | 1.02x | zł57.08K |
| 2013 | 13.44% | 69.27% | 0.19x | 1.03x | zł2.78 Million |
| 2014 | 16.00% | 48.89% | 0.31x | 1.05x | zł5.45 Million |
| 2015 | 14.04% | 28.23% | 0.48x | 1.03x | zł4.01 Million |
| 2016 | 22.66% | 31.35% | 0.35x | 2.09x | zł22.41 Million |
| 2017 | 15.12% | 12.56% | 0.70x | 1.71x | zł8.65 Million |
| 2018 | 7.59% | 7.23% | 0.63x | 1.66x | zł-4.57 Million |
| 2019 | -0.15% | -0.17% | 0.61x | 1.45x | zł-19.88 Million |
| 2020 | -6.23% | -11.56% | 0.39x | 1.37x | zł-33.65 Million |
| 2021 | -381.21% | -373.61% | 0.42x | 2.41x | zł-185.38 Million |
| 2022 | -12.53% | -18.91% | 0.58x | 1.15x | zł-21.33 Million |
| 2023 | -0.62% | -1.34% | 0.35x | 1.31x | zł-9.83 Million |
| 2024 | -20.84% | -67.00% | 0.23x | 1.37x | zł-23.80 Million |
Industry Comparison
This section compares Medicalg's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $19,171,466
- Average return on equity (ROE) among peers: -205.27%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medicalg (MDG) | zł62.94 Million | 67.51% | 0.77x | $74.23 Million |
| Adiuvo Investment SA (ADV) | $-44.73 Million | 0.00% | 0.00x | $1.81 Million |
| Braster S.A. (BRA) | $29.02 Million | -68.18% | 0.88x | $4.69 Million |
| Genomtec S.A. (GMT) | $738.00K | -964.09% | 4.71x | $21.68 Million |
| Medinice S.A (ICE) | $40.58 Million | -7.10% | 0.21x | $206.77 Million |
| Synektik S.A. (SNT) | $70.25 Million | 13.00% | 0.78x | $748.80 Million |
About Medicalg
Medicalgorithmics S.A. provides cardiac diagnostic solutions in Poland, the United States, and internationally. It offers PocketECG, an AI-driven online ECG monitoring device for long-term holter, cardiac event, and mobile cardiac telemetry analysis; Kardiobeat.ai, an AI-Driven lightweight wireless holter monitor; DeepRhythm Platform, a hardware-agnostic cloud-based software that leverages cuttin… Read more